Biomarin Pharmaceutical Inc (BMRN)

Exchange
NASDAQ
Symbol
BMRN
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
Country
USA

Stock price

At close: November 20, 2024

  • Open
    61.97
  • High
    62.70
  • Low
    61.61
  • Close
    62.56
  • Volume
    1,245,560

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
0.45
Receivables turnover
3.83
Payables turnover
—
Working capital turnover
1.29
Days of inventory on hand (DOH)
808.91
Days of sales outstanding (DSO)
95.20
Number of days of payables
—
Fixed asset turnover
2.30
Total asset turnover
0.36
 Liquidity ratios
Current ratio
2.74
Quick ratio
1.55
Cash ratio
0.96
Cash conversion cycle
904.10
 Solvency ratios
Debt-to-assets ratio
0.09
Debt-to-capital ratio
0.10
Debt-to-equity ratio
0.12
Financial leverage ratio
1.35
Interest coverage
14.82
 Profitability ratios
Gross profit margin
78.98%
Operating profit margin
7.66%
Pretax margin
9.72%
Net profit margin
8.41%
Operating return on assets (Operating ROA)
2.72%
Return on assets (ROA)
2.99%
Return on total capital
4.49%
Return on equity (ROE)
4.05%